✦ LIBER ✦

Molecular basis of the inflammatory response to adenovirus vectors

✍ Scribed by Liu, Q; Muruve, D A

Book ID: 110039335
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 107 KB
Volume: 10
Category: Article
ISSN: 0969-7128
DOI: 10.1038/sj.gt.3302036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strong foreign promoters contribute to i

Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors

✍ Jerome Schaack; Michael L. Bennett; Gary S. Shapiro; James DeGregori; James L. M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Humoral immune responses to adenovirus v

Humoral immune responses to adenovirus vectors in the brain

✍ Koji Kajiwara; Andrew P Byrnes; Yoshinori Ohmoto; Harry M Charlton; Matthew J.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Immune responses to adenovirus vectors i

Immune responses to adenovirus vectors in the nervous system

✍ Matthew J.A. Wood; Harry M. Charlton; Kathryn J. Wood; Koji Kajiwara; Andrew P. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Inflammatory responses and their impact

Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus

✍ Lawrence, M S; Foellmer, H G; Elsworth, J D; Kim, J H; Leranth, C; Kozlowski, D 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 343 KB

Molecular Basis of the Immune Response

✍ C. I. E. Smith 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

The role of IL-6 in the inflammatory and

The role of IL-6 in the inflammatory and humoral response to adenoviral vectors

✍ Karim Benihoud; Barbara Salone; Stephanie Esselin; Paule Opolon; Valeria Poli; M 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 2 views

Background The major concern for the use of adenoviral vectors for gene therapy is the viral-induced immune response that has been shown to be responsible for short-term transgene expression and inef®cient viral readministration. In vivo studies and clinical trials with recombinant adenovirus have s